WealthTrust Axiom’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-60,000
| Closed | -$71K | – | 260 |
|
|
2022
Q3 | $71K | Buy |
60,000
+5,000
| +9% | +$5.92K | 0.03% | 225 |
|
|
2022
Q2 | $99K | Buy |
55,000
+23,000
| +72% | +$41.4K | 0.04% | 225 |
|
|
2022
Q1 | $64K | Buy |
32,000
+2,000
| +7% | +$4K | 0.02% | 250 |
|
|
2021
Q4 | $81K | Buy |
30,000
+3,000
| +11% | +$8.1K | 0.03% | 244 |
|
|
2021
Q3 | $120K | Sell |
27,000
-3,000
| -10% | -$13.3K | 0.04% | 232 |
|
|
2021
Q2 | $174K | Buy |
30,000
+10,000
| +50% | +$58K | 0.06% | 239 |
|
|
2021
Q1 | $140K | Buy |
20,000
+8,000
| +67% | +$56K | 0.05% | 226 |
|
|
2020
Q4 | $57K | Buy |
12,000
+2,000
| +20% | +$9.5K | 0.02% | 231 |
|
|
2020
Q3 | $58K | Buy |
+10,000
| New | +$58K | 0.03% | 197 |
|